iShares Biotechnology ETF (NASDAQ:IBB) Shares Bought by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 805.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 32,084 shares of the financial services provider’s stock after acquiring an additional 28,541 shares during the quarter. Kingsview Wealth Management LLC owned about 0.07% of iShares Biotechnology ETF worth $4,242,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in IBB. BNP Paribas Financial Markets lifted its holdings in shares of iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after buying an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares during the period. Aprio Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at $18,476,000. DRW Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at $5,990,000. Finally, Erste Asset Management GmbH acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at $5,678,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $137.67 on Friday. The business has a fifty day simple moving average of $136.22 and a 200-day simple moving average of $141.38. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.